Csenge Advisory Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Buy |
18,408
+432
| +2% | +$50K | 0.11% | 152 |
|
|
2025
Q1 | $1.99M | Buy |
17,976
+1,581
| +10% | +$175K | 0.11% | 149 |
|
|
2024
Q4 | $1.6M | Buy |
16,395
+6,369
| +64% | +$620K | 0.09% | 188 |
|
|
2024
Q3 | $1.17M | Buy |
10,026
+678
| +7% | +$78.8K | 0.06% | 233 |
|
|
2024
Q2 | $995K | Buy |
9,348
+2,792
| +43% | +$297K | 0.06% | 251 |
|
|
2024
Q1 | $634K | Sell |
6,556
-1,365
| -17% | -$132K | 0.04% | 372 |
|
|
2023
Q4 | $800K | Buy |
7,921
+806
| +11% | +$81.4K | 0.05% | 288 |
|
|
2023
Q3 | $725K | Buy |
7,115
+3,709
| +109% | +$378K | 0.05% | 279 |
|
|
2023
Q2 | $344K | Buy |
+3,406
| New | +$344K | 0.02% | 465 |
|
|
2021
Q2 | – | Sell |
-2,312
| Closed | -$202K | – | 575 |
|
|
2021
Q1 | $202K | Sell |
2,312
-151
| -6% | -$13.2K | 0.02% | 475 |
|
|
2020
Q4 | $233K | Sell |
2,463
-449
| -15% | -$42.5K | 0.03% | 384 |
|
|
2020
Q3 | $252K | Buy |
2,912
+47
| +2% | +$4.07K | 0.03% | 329 |
|
|
2020
Q2 | $250K | Sell |
2,865
-552
| -16% | -$48.2K | 0.04% | 310 |
|
|
2020
Q1 | $282K | Buy |
+3,417
| New | +$282K | 0.07% | 223 |
|
|
2018
Q4 | – | Sell |
-23
| Closed | -$1K | – | 1059 |
|
|
2018
Q3 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 899 |
|